The earlier it's detected, the earlier treatment can start.

It’s “a move away from a one-size-fits-all framework for Alzheimer’s disease.” ...

Boston coverage of the paper has underscored how Mass General Brigham investigators are helping “push back the clock” on ...

Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.

A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an ...

Nearly two out of every three Americans living with Alzheimer’s disease are women, according to the Alzheimer’s Association, ...

The secret might be hidden in our blood. Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. The ...

This suggests that some biological pathways leading to Alzheimer's may become active decades before symptoms emerge, ...

A new study challenges the long-standing view that Alzheimer’s is driven primarily by amyloid plaques, instead pointing to a subtle but critical competition inside neurons.

Mahmood’s interest in neuroscience led her to Indianapolis in summer 2025, where she helped with student research into early ...

A raffle in France is offering the chance to win a portrait by Pablo Picasso for the price of a 100 euro ($117) ticket, with ...